Such a waiver would “certainly help to override Merck and Pfizer’s patent and data protection rights in one fell swoop, reducing the need for country-by-countries solutions, including compulsory licenses,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on equity in […]